Fundraising FoxEnodia Therapeutics
4 known investors
Find your way into Enodia Therapeutics
Sign up to find every way you can get introduced to Enodia Therapeutics
- Your email: who you already know at Enodia Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Enodia Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Enodia Therapeutics develops small-molecule therapies that target protein degradation at the point of synthesis using a machine learning-enabled platform. The company serves the therapeutic development market with its targeted protein degradation approach.
Founders & leadership
YR
Yves RibeillCEO
Investors · 4
Bpifrance✓ confirmed by Enodia TherapeuticsParis, Ile-De-France · $270K
How we know: the company's own site · Not right? Tell us
Elaia✓ confirmed by Enodia TherapeuticsParis · $108K – $1.6M
How we know: the company's own site · Not right? Tell us
Pfizer Ventures✓ confirmed by Enodia Therapeutics
How we know: the company's own site · Not right? Tell us
Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M
How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Enodia Therapeutics do?
- Enodia Therapeutics develops small-molecule therapies that target protein degradation at the point of synthesis using a machine learning-enabled platform. The company serves the therapeutic development market with its targeted protein degradation approach.
- Who are Enodia Therapeutics's investors?
- Enodia Therapeutics's investors include Bpifrance, Elaia, Pfizer Ventures, Pfizer Venture Investments.